The frequencies of VTE did not differ significantly based on INR range or receipt of VTE prophylaxis. Of the 190 patients in the study, 17 (9%) received pharmacologic VTE prophylaxis and 31 (16% ...

Data in the medical literature clearly demonstrate the benefit of prophylaxis for venous thromboembolism (VTE), and current guidelines recommend VTE prophylaxis for most hospitalized patients. 1 ...

Post-transplant cyclophosphamide (PTCy) plus cyclosporine is more effective than standard graft-vs-host disease (GVHD) prophylaxis in patients undergoing matched sibling peripheral blood stem cell ...

Introduction Hospital-acquired thrombosis accounts for a large proportion of all venous thromboembolism (VTE), with significant morbidity and mortality. This subset of VTE can be reduced through ...

Citation Kolkailah AA, Abdelghaffar B, Elshafeey F, Magdy R, Kamel M, Abuelnaga Y, Nabhan AF, Piazza G. Standard- versus extended-duration anticoagulation for primary venous thromboembolism ...

Overall, 92% of patients in group 3 were provided some form of VTE prophylaxis ( Table 4 ). This represents better than a 2.7-fold increase in VTE prophylaxis as compared with groups 1 and 2 (34% ...

SAN FRANCISCO — Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with sepsis-associated respiratory failure and cytomegalovirus ...